Search Results - "Affrime, MB"
-
1
QT and QTc Interval With Standard and Supratherapeutic Doses of Darifenacin, a Muscarinic M 3 Selective Receptor Antagonist for the Treatment of Overactive Bladder
Published in Journal of clinical pharmacology (01-09-2005)“…Prolongation of QT interval on an electrocardiogram is a valuable predictor of a drug's ability to cause potentially fatal ventricular tachyarrhythmia…”
Get full text
Journal Article -
2
Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations
Published in Clinical pharmacology and therapeutics (01-09-1995)“…To evaluate the effects of coadministration of loratadine and erythromycin on the pharmacokinetics and electrocardiographic repolarization (QTc)…”
Get more information
Journal Article -
3
Comparative Pharmacokinetics of Oral Ceftibuten, Cefixime, Cefaclor, and Cefuroxime Axetil in Healthy Volunteers
Published in Pharmacotherapy (01-01-1997)“…Study Objective. To compare the pharmacokinetics of ceftibuten, cefixime, cefuroxime axetil, and cefaclor after oral administration. Design. Randomized,…”
Get full text
Journal Article -
4
Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin
Published in British journal of clinical pharmacology (01-09-2002)“…Aims The primary aims of these two single‐centre, randomized, evaluator‐blind, placebo/positive‐controlled, parallel‐group studies were to evaluate the…”
Get full text
Journal Article -
5
Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses
Published in Chest (01-12-2000)“…To investigate the potential for mometasone furoate (MF) to exert systemic effects following administration by dry powder inhaler (DPI) or metered-dose inhaler…”
Get more information
Journal Article -
6
Ribavirin dosing in chronic hepatitis C: Application of population pharmacokinetic-pharmacodynamic models
Published in Clinical pharmacology and therapeutics (01-10-2002)“…Background Combination therapy of ribavirin with interferon alfa‐2b and pegylated interferon alfa‐2b is currently approved for the treatment of chronic…”
Get full text
Journal Article -
7
Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration
Published in The Journal of immunology (1950) (15-04-1997)“…To determine the effects of IL-10 on cytokine and granulocyte responses during endotoxemia, two groups of eight healthy male volunteers were challenged with…”
Get full text
Journal Article -
8
In vivo effects of interleukin-10 on human cytochrome P450 activity
Published in Clinical pharmacology and therapeutics (01-01-2000)“…Background Injection of lipopolysaccharide into human volunteers leads to an increase in serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α and a…”
Get full text
Journal Article -
9
Bioavailability and Metabolism of Mometasone Furoate following Administration by Metered-Dose and Dry-Powder Inhalers in Healthy Human Volunteers
Published in Journal of clinical pharmacology (01-11-2000)“…These studies were conducted to assess the systemic bioavailability of mometasone furoate (MF) administered by both the dry‐powder inhaler (DPI) and the…”
Get full text
Journal Article -
10
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers
Published in Clinical pharmacology and therapeutics (01-08-1997)“…Interleukin‐10 inhibits T‐lymphocyte activation and proliferation and lipopolysaccharide‐induced monocyte production of proinflammatory cytokines. Fifty‐four…”
Get full text
Journal Article -
11
Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children
Published in Clinical therapeutics (01-11-1997)“…Sensitive and reproducible assessments of hypothalamic-pituitary-adrenal (HPA) axis function were used to assess the systemic exposure and tolerability of…”
Get full text
Journal Article Conference Proceeding -
12
Pharmacokinetics and Immunomodulatory Properties of Intravenously Administered Recombinant Human Interleukin-10 in Healthy Volunteers
Published in Blood (15-01-1996)“…Normal volunteers received single doses of recombinant human interleukin-10 (rhIL-10; n = 6 per group) or placebo (n = 3 per group) by intravenous injection to…”
Get full text
Journal Article -
13
Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine
Published in British journal of clinical pharmacology (01-12-2000)“…Aims To evaluate whether ketoconazole or cimetidine alter the pharmacokinetics of loratadine, or its major metabolite, desloratadine (DCL), or alter the…”
Get full text
Journal Article -
14
Population pharmacokinetics of temozolomide in cancer patients
Published in Pharmaceutical research (01-10-2000)“…To evaluate covariate effects on the pharmacokinetics of temozolomide in cancer patients, and to explore the dose-pharmacokinetics-toxicity relationship of…”
Get full text
Journal Article -
15
The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years
Published in Clinical therapeutics (01-05-2000)“…Abstract We assessed the pharmacokinetics and tolerability of 5 mg loratadine syrup (1 mg/mL) in children aged 2 to 5 years. Two studies were undertaken. A…”
Get full text
Journal Article -
16
Pharmacokinetics and leukocyte responses of recombinant human interleukin-10
Published in Pharmaceutical research (01-12-1998)“…To study the pharmacokinetics and ex vivo leukocyte responses of recombinant human IL-10 (rHuIL-10) following single s.c. and i.v. dosing. A randomized two-way…”
Get full text
Journal Article -
17
Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology
Published in The European respiratory journal (01-07-2001)Get full text
Journal Article -
18
Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler
Published in Clinical therapeutics (01-12-2000)“…Background: A new inhaled suspension formulation of mometasone furoate (MF), a potent corticosteroid with minimal systemic availability, has been developed for…”
Get full text
Journal Article -
19
Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive
Published in Clinical pharmacology and therapeutics (01-11-1995)“…The effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive containing 30 micrograms ethinyl estradiol and 75 micrograms…”
Get more information
Journal Article -
20
Clinical, hematologic, and immunologic effects of interleukin-10 in humans
Published in Journal of clinical immunology (01-09-1996)“…We conducted a double-blind, placebo-controlled study to investigate the safety, pharmacokinetics, and immunological properties of interleukin-10 (IL-10)…”
Get full text
Journal Article